1. Home
  2. POAI vs SYTA Comparison

POAI vs SYTA Comparison

Compare POAI & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • SYTA
  • Stock Information
  • Founded
  • POAI 2002
  • SYTA N/A
  • Country
  • POAI United States
  • SYTA Canada
  • Employees
  • POAI N/A
  • SYTA 24
  • Industry
  • POAI Industrial Specialties
  • SYTA Telecommunications Equipment
  • Sector
  • POAI Health Care
  • SYTA Telecommunications
  • Exchange
  • POAI Nasdaq
  • SYTA Nasdaq
  • Market Cap
  • POAI 8.9M
  • SYTA 10.7M
  • IPO Year
  • POAI N/A
  • SYTA 2020
  • Fundamental
  • Price
  • POAI $0.89
  • SYTA $2.03
  • Analyst Decision
  • POAI Hold
  • SYTA
  • Analyst Count
  • POAI 1
  • SYTA 0
  • Target Price
  • POAI N/A
  • SYTA N/A
  • AVG Volume (30 Days)
  • POAI 93.9K
  • SYTA 2.0M
  • Earning Date
  • POAI 08-12-2025
  • SYTA 08-15-2025
  • Dividend Yield
  • POAI N/A
  • SYTA N/A
  • EPS Growth
  • POAI N/A
  • SYTA N/A
  • EPS
  • POAI N/A
  • SYTA N/A
  • Revenue
  • POAI $1,729,269.00
  • SYTA $11,740,024.00
  • Revenue This Year
  • POAI $486.27
  • SYTA $18.41
  • Revenue Next Year
  • POAI $65.50
  • SYTA N/A
  • P/E Ratio
  • POAI N/A
  • SYTA N/A
  • Revenue Growth
  • POAI 24.17
  • SYTA 33.58
  • 52 Week Low
  • POAI $0.55
  • SYTA $0.93
  • 52 Week High
  • POAI $3.06
  • SYTA $162.90
  • Technical
  • Relative Strength Index (RSI)
  • POAI 38.00
  • SYTA 43.33
  • Support Level
  • POAI $0.85
  • SYTA $1.83
  • Resistance Level
  • POAI $0.91
  • SYTA $2.30
  • Average True Range (ATR)
  • POAI 0.06
  • SYTA 0.32
  • MACD
  • POAI -0.00
  • SYTA -0.13
  • Stochastic Oscillator
  • POAI 4.12
  • SYTA 12.12

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About SYTA Siyata Mobile Inc.

Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.

Share on Social Networks: